New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 12, 2014
08:32 EDTOVASOvaScience issued two U.S. patents covering AUGMENT fertility treatment
OvaScience announced the issuance of two United States patents covering its AUGMENT fertility treatment. AUGMENT is based on the company’s egg precursor cell technology and is being developed to improve egg quality and the success of in vitro fertilization. AUGMENT will be available in international IVF clinics this year. The issuance of these two patents builds upon the company’s Composition of Matter patent on EggPCs, and provides further protection for AUGMENT through at least 2032. The newly issued patents broadly cover the AUGMENT process, including: IVF by AUGMENT; preparing an egg for use with assisted reproductive technologies; and increasing the energy-generating capacity of an egg by AUGMENT. OvaScience plans to introduce AUGMENT this year through an international program called ‘ACE’ or AUGMENT Centers of Excellence, which will enable physicians to gain experience using AUGMENT and generate data. The Company expects to establish ACE clinics in at least four international regions and record 40 to 60 AUGMENT cycles in 2014
News For OVAS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 18, 2014
08:31 EDTOVASOvaScience names Jeffrey Young as CFO
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use